SEC Form D · filed June 5, 2018
Vedantra Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Isaac Blech · Cambridge, MADirectorDaniel Geffken · CAMBRIDGE, MAExec · DirectorSatish Jindal · Cambridge, MADirectorJulian Adams · CAMBRIDGE, MADirectorFrank Haluska · CAMBRIDGE, MADirectorIsaac Kohlberg · Cambridge, MADirectorWilliam Koster · Providence, RIDirectorD. J. Durivage · Dublin, OHDirectorMichael E. Edleson · Grand Cayman, Cayman IslandsDirectorMatthew J. Aiello · Crownsville, MDExec · DirectorW. G. Cole · Watkinsville, GADirectorGary R. Peterson · Houston, TXDirectorVincent G. Pollesel · Garson, Ontario, CanadaDirectorMatt F. Lopez · Ladera Ranch, CADirectorMatt Belcher · San Diego, CADirectorStephanie Sy · San Diego, CAExec · DirectorWalter H. Berukoff · NORTH VANCOUVER, British Columbia, CanadaDirectorMaren Steinberg · DENVER, CODirectorStephen H. Mann · NORTH VANCOUVER, British Columbia, CanadaDirectorRichard H. Meli · NORTH VANCOUVER, British Columbia, CanadaDirectorTony H. Young · NORTH VANCOUVER, British Columbia, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗